CTRI/2023/11/060006尚未招募4 期
Antifactor Xa levels vs. activated partial thromboplastin time (aPTT) for monitoring Low-molecular weight heparin (LMWH) Residual Activity In Patients Presenting For Elective Surgery:A Comparative Study. - NI
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1)To be on prophylactic dose of Inj. Enoxaparin at the time of presentation for elective surgery
- •2)Must be able to accurately report the timing of their last dose and the administered dosage.
- •3)Patients must also be between the ages of 18-80 years of age
- •4) Must be able to give written consent to participate.
排除标准
- •1) Factors known to interfere with aPTT monitoring such as lupus anticoagulant disease, clotting factor deficiencies (factor V, VIII, IX, X, XI, XII and von Willebrand disease), severe liver disease, acquired vitamin K deficiency, antithrombin (AT) III deficiency, elevated levels of clotting factors, pregnancy and increased factor VIII level.
- •2) Patients who are receiving enoxaparin as a bridge from another anti-Xa inhibiting medication will be excluded as this could unpredictably affect the results of anti-Xa testing. These medications include: Apixaban, Edoxaban, Fondaparinux, and Xarelto.
研究者
相似试验
已完成
不适用
Comparative anti-Factor Xa activity between standard dose and Japanese dose of rivaroxaban in Thai patients with non-valvular atrial fibrillatioon-valvular Atrial Fibrillation.-Non-valvular Atrial Fibrillationanti-XA activityRivaroxaban standard doseRivaroxaban Japanese doseTCTR20181104002Faculty of Medicine, Chiang Mai University60
进行中（未招募）
1 期
During atrial fibrillation catheter ablation procedure treatment with anticoagulant drugs is necessary in order to prevent blood clotting and thereby decrease the risk of procedure related strokes. In this study two different types of anticoagulant drugs are being compared during and after the atrial fibrillation catheter ablation procedure: the novel direct factor Xa inhibitor apixaban and any of the standard vitamin K antagonists.Atrial fibrillation catheter ablationMedDRA version: 19.1Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 19.1Level: LLTClassification code 10071667Term: Persistent atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 19.1Level: LLTClassification code 10003661Term: Atrial fibrillation paroxysmalSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 19.1Level: LLTClassification code 10066582Term: Recurrent atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersEUCTR2014-002442-45-ATKompetenznetz Vorhofflimmern e.V. (AFNET) [Atrial Fibrillation NETwork]650
进行中（未招募）
1 期
During atrial fibrillation catheter ablation procedure treatment with anticoagulant drugs is necessary in order to prevent blood clotting and thereby decrease the risk of procedure related strokes. In this study two different types of anticoagulant drugs are being compared during and after the atrial fibrillation catheter ablation procedure: the novel direct factor Xa inhibitor apixaban and any of the standard vitamin K antagonist.EUCTR2014-002442-45-DEKompetenznetz Vorhofflimmern e.V. [Atrial Fibrillation NETwork (AFNET)]650
进行中（未招募）
1 期
During atrial fibrillation catheter ablation procedure treatment with anticoagulant drugs is necessary in order to prevent blood clotting and thereby decrease the risk of procedure related strokes. In this study two different types of anticoagulant drugs are being compared during and after the atrial fibrillation catheter ablation procedure: the novel direct factor Xa inhibitor apixaban and any of the standard vitamin K antagonists.Atrial fibrillation catheter ablationMedDRA version: 18.0Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 18.0Level: LLTClassification code 10071667Term: Persistent atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 18.0Level: LLTClassification code 10066582Term: Recurrent atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 18.0Level: LLTClassification code 10003661Term: Atrial fibrillation paroxysmalSystem Organ Class: 10007541 - Cardiac disordersEUCTR2014-002442-45-ESThe Kompetenznetz Vorhofflimmern e.V. [German Atrial Fibrillation Competence Network association (AFNET e.V.)]650
进行中（未招募）
1 期
During atrial fibrillation catheter ablation procedure treatment with anticoagulant drugs is necessary in order to prevent blood clotting and thereby decrease the risk of procedure related strokes. In this study two different types of anticoagulant drugs are being compared during and after the atrial fibrillation catheter ablation procedure: the novel direct factor Xa inhibitor apixaban and any of the standard vitamin K antagonist.EUCTR2014-002442-45-BEThe Kompetenznetz Vorhofflimmern e.V. [German Atrial Fibrillation Competence Network association (AFNET e.V.)]650